Boston Scientific (BSX) Ratios
Boston Scientific Ratios
MX:BSX's free cash flow for Q2 2026 was $1.28B. For the 2026 fiscal year, MX:BSX's free cash flow was decreased by $-195.00M and operating cash flow was $1.47B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.62 | 1.08 | 1.32 | 1.51 | 1.48 |
| Quick Ratio | 1.08 | 0.64 | 0.82 | 1.02 | 1.10 |
| Cash Ratio | 0.38 | 0.06 | 0.18 | 0.24 | 0.45 |
| Solvency Ratio | 0.22 | 0.18 | 0.18 | 0.12 | 0.14 |
| Operating Cash Flow Ratio | 0.83 | 0.54 | 0.51 | 0.40 | 0.44 |
| Short-Term Operating Cash Flow Coverage | 11.66 | 1.93 | 4.71 | 76.30 | 7.16 |
| Net Current Asset Value | $ -10.41B | $ -10.47B | $ -9.09B | $ -9.14B | $ -9.29B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.28 | 0.28 | 0.27 | 0.29 | 0.29 |
| Debt-to-Equity Ratio | 0.51 | 0.51 | 0.49 | 0.53 | 0.57 |
| Debt-to-Capital Ratio | 0.34 | 0.34 | 0.33 | 0.35 | 0.36 |
| Long-Term Debt-to-Capital Ratio | 0.32 | 0.29 | 0.31 | 0.34 | 0.35 |
| Financial Leverage Ratio | 1.80 | 1.81 | 1.82 | 1.85 | 1.94 |
| Debt Service Coverage Ratio | 6.25 | 1.62 | 3.81 | 4.75 | 4.07 |
| Interest Coverage Ratio | 11.38 | 6.81 | 8.02 | 3.93 | 5.51 |
| Debt to Market Cap | 0.08 | 0.08 | 0.11 | 0.13 | 0.15 |
| Interest Debt Per Share | 8.62 | 7.84 | 6.72 | 6.81 | 6.89 |
| Net Debt to EBITDA | 2.03 | 2.73 | 2.50 | 3.05 | 2.99 |
| Profitability Margins | |||||
| Gross Profit Margin | 69.01% | 61.31% | 62.02% | 60.83% | 62.76% |
| EBIT Margin | 18.60% | 15.94% | 15.85% | 12.66% | 11.99% |
| EBITDA Margin | 25.42% | 23.51% | 24.25% | 21.61% | 21.18% |
| Operating Profit Margin | 19.78% | 15.73% | 15.32% | 14.38% | 16.17% |
| Pretax Profit Margin | 16.86% | 13.63% | 13.94% | 9.00% | 9.05% |
| Net Profit Margin | 14.38% | 11.07% | 11.19% | 5.50% | 8.75% |
| Continuous Operations Profit Margin | 14.41% | 11.02% | 11.18% | 5.50% | 8.75% |
| Net Income Per EBT | 85.26% | 81.24% | 80.25% | 61.17% | 96.65% |
| EBT Per EBIT | 85.24% | 86.60% | 91.01% | 62.55% | 55.98% |
| Return on Assets (ROA) | 6.61% | 4.71% | 4.53% | 2.15% | 3.23% |
| Return on Equity (ROE) | 11.91% | 8.52% | 8.26% | 3.97% | 6.26% |
| Return on Capital Employed (ROCE) | 10.39% | 7.99% | 7.22% | 6.36% | 6.88% |
| Return on Invested Capital (ROIC) | 8.78% | 6.13% | 5.69% | 3.89% | 6.58% |
| Return on Tangible Assets | 15.71% | 11.87% | 10.80% | 5.11% | 7.36% |
| Earnings Yield | 2.04% | 1.41% | 1.90% | 1.05% | 1.72% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.86 | 6.55 | 6.39 | 6.44 | 6.69 |
| Payables Turnover | 5.44 | 6.75 | 5.74 | 5.76 | 5.58 |
| Inventory Turnover | 2.11 | 2.31 | 2.18 | 2.66 | 2.75 |
| Fixed Asset Turnover | 4.46 | 4.47 | 4.32 | 4.48 | 4.43 |
| Asset Turnover | 0.46 | 0.43 | 0.41 | 0.39 | 0.37 |
| Working Capital Turnover Ratio | 10.36 | 15.93 | 8.05 | 6.34 | 4.70 |
| Cash Conversion Cycle | 158.81 | 159.96 | 161.16 | 130.54 | 121.87 |
| Days of Sales Outstanding | 53.20 | 55.75 | 57.11 | 56.70 | 54.59 |
| Days of Inventory Outstanding | 172.73 | 158.28 | 167.62 | 137.17 | 132.74 |
| Days of Payables Outstanding | 67.12 | 54.07 | 63.57 | 63.33 | 65.46 |
| Operating Cycle | 225.93 | 214.03 | 224.73 | 193.87 | 187.33 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 3.06 | 2.33 | 1.72 | 1.07 | 1.31 |
| Free Cash Flow Per Share | 2.47 | 1.80 | 1.17 | 0.64 | 0.93 |
| Dividend Paid and CapEx Coverage Ratio | 5.18 | 4.35 | 3.02 | 2.29 | 3.07 |
| Capital Expenditure Coverage Ratio | 5.18 | 4.35 | 3.13 | 2.49 | 3.38 |
| Operating Cash Flow Coverage Ratio | 0.37 | 0.31 | 0.26 | 0.16 | 0.20 |
| Operating Cash Flow to Sales Ratio | 0.23 | 0.21 | 0.18 | 0.12 | 0.16 |
| Free Cash Flow Yield | 2.59% | 2.01% | 2.03% | 1.38% | 2.18% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 48.65 | 70.89 | 52.73 | 94.83 | 58.10 |
| Price-to-Sales (P/S) Ratio | 7.03 | 7.85 | 5.90 | 5.22 | 5.08 |
| Price-to-Book (P/B) Ratio | 5.82 | 6.04 | 4.36 | 3.77 | 3.63 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 38.59 | 49.69 | 49.32 | 72.42 | 45.91 |
| Price-to-Operating Cash Flow Ratio | 31.13 | 38.26 | 33.56 | 43.37 | 32.31 |
| Price-to-Earnings Growth (PEG) Ratio | 0.88 | 4.27 | 0.37 | -2.69 | -0.06 |
| Enterprise Value Multiple | 29.70 | 36.10 | 26.82 | 27.20 | 26.98 |
| Enterprise Value | 151.53B | 142.17B | 92.62B | 74.54B | 67.95B |
| EV to EBITDA | 29.70 | 36.10 | 26.82 | 27.20 | 26.98 |
| EV to Sales | 7.55 | 8.49 | 6.50 | 5.88 | 5.72 |
| EV to Free Cash Flow | 41.42 | 53.75 | 54.39 | 81.56 | 51.63 |
| EV to Operating Cash Flow | 33.42 | 41.39 | 37.01 | 48.85 | 36.33 |
| Tangible Book Value Per Share | -0.56 | -1.20 | -0.59 | -0.87 | -1.04 |
| Shareholders’ Equity Per Share | 16.37 | 14.79 | 13.27 | 12.29 | 11.69 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.15 | 0.19 | 0.20 | 0.39 | 0.03 |
| Revenue Per Share | 13.56 | 11.38 | 9.80 | 8.87 | 8.36 |
| Net Income Per Share | 1.95 | 1.26 | 1.10 | 0.49 | 0.73 |
| Tax Burden | 0.85 | 0.81 | 0.80 | 0.61 | 0.97 |
| Interest Burden | 0.91 | 0.86 | 0.88 | 0.71 | 0.76 |
| Research & Development to Revenue | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 |
| SG&A to Revenue | 0.34 | 0.36 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 |
| Income Quality | 1.57 | 1.86 | 1.57 | 2.19 | 1.80 |
Currency in USD